🇺🇸 FDA
Patent

US 8182836

Abuse-resistant oral dosage forms and method of use thereof

granted A61KA61K31/485A61K9/1676

Quick answer

US patent 8182836 (Abuse-resistant oral dosage forms and method of use thereof) held by Elite Laboratories, Inc. expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Elite Laboratories, Inc.
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/485, A61K9/1676, A61K9/4808, A61K9/5026